Anti-proliferative effect of rhein, an anthraquinone isolated from Cassia species, on Caco-2 human adenocarcinoma cells

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 7, 2010, Pages 2006-2014

  Aviello, Gabriella ^a   Rowland, Ian ^b   Gill, Christopher I ^c   Acquaviva, Angela Maria ^a   Capasso, Francesco ^a   McCann, Mark ^c   Capasso, Raffaele ^a   Izzo, Angelo A ^a   Borrelli, Francesca ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF READING   (United Kingdom)

^c UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Antioxidant; Genoprotection; Human colon adenocarcinoma cells; Mitogen activated protein kinase; Rhein

Indexed keywords

CASSIA; SENNA;

EID: 77955782186     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00815.x     Document Type: Article

References (58)

1. Müller-Lissner SA, Kamm MA, Scarpignato C. Myths and misconceptions about chronic constipation. Am J Gastroenterol. 2005, 100:232-42.
2. Wald A. Pathophysiology, diagnosis and current management of chronic constipation. Nat Clin Pract Gastroenterol Hepatol. 2006, 3:90-100.
3. Capasso F, Gaginella TS. Laxative. A practical guide 1997, Milan, Springer-Verlag
4. Lemli J, Lemmens L. Metabolism of sennosides and rhein in the rat. Pharmacol. 1980, 20:50-7.
5. Capasso F, Gaginella TS, Grandolini G. Phytotherapy: a quick reference to herbal medicine 2003, New York, Springer-Verlag
6. Leng-Peschlow E. Dual effect of orally administered sennosides on large intestine transit and fluid absorption in the rat. J Pharm Pharmacol. 1986, 38:606-10.
7. Riecken EO, Zeitz M, Emde C. The effect of an anthraquinone laxative on colonic nerve tissue: a controlled trial in constipated women. Z Gastroenterol. 1990, 28:660-4.
8. Joo JS, Ehrenpreis ED, Gonzalez L. Alterations in colonic anatomy induced by chronic stimulant laxatives: the cathartic colon revisited. J Clin Gastroenterol. 1998, 26:283-6.
9. Villanacci V, Bassotti G, Cathomas G. Is pseudomelanosis coli a marker of colonic neuropathy in severely constipated patients. Histopathology. 2006, 49:132-7.
10. van Gorkom BA, Karrenbeld A, Koudstaal J. Effects of sennosides on colonic epithelial cell proliferation and bcl-2 gene expression: possible mechanisms for carcinogenic effects abstract. Gastroenterology 1996, 110:A608.
11. van Gorkom BA, Karrenbeld A, van Der Sluis T. Influence of a highly purified senna extract on colonic epithelium. Digestion. 2000, 61:113-20.
12. van Gorkom BA, Karrenbeld A, van der Sluis T. Apoptosis induction by sennoside laxatives in man; escape from a protective mechanism during chronic sennoside use. J Pathol. 2001, 194:493-9.
13. Kune GA. Laxative use not a risk for colorectal cancer: data from the Melbourne Colorectal Cancer Study. Z Gastroenterol. 1993, 31:140-3.
14. Nusko G, Schneider B, Muller G. Retrospective study on laxative use and melanosis coli as risk factors for colorectal neoplasma. Pharmacology. 1993, 47:234-41.
15. Nusko G, Schneider B, Schneider I. Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study. Gut. 2000, 46:651-5.
16. Nascimbeni R, Donato F, Ghirardi M. Constipation, anthranoid laxatives, melanosis coli, and colon cancer: a risk assessment using aberrant crypt foci. Cancer Epidemiol Biomarkers Prev. 2002, 11:753-7.
17. Roberts MC, Millikan RC, Galanko JA. Constipation, laxative use, and colon cancer in a North Carolina population. Am J Gastroenterol. 2003, 98:857-64.
18. Siegers CP, von Hertzberg-Lottin E, Otte M. Anthranoid laxative abuse-a risk for colorectal cancer. Gut. 1993, 34:1099-101.
19. Patel PM, Selby PJ, Deacon J. Anthraquinone laxatives and human cancer: an association in one case. Postgrad Med J. 1989, 65:216-7.
20. Kleibeuker JH, Cats A, Zwart N. Excessively high cell proliferation in sigmoid colon after an oral purge with anthraquinone glycosides. J Natl Cancer Inst. 1995, 87:452-3.
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983, 65:55-63.
22. Repetto G, del Peso A, Zurita JL. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc. 2008, 3:1125-31.
23. Leonard M, Creed E, Brayden D. Evaluation of the Caco-2 monolayer as a model epithelium for ionophoretic transport. Pharm Res. 2002, 17:1181-8.
24. Leone V, di Palma A, Ricchi P. PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP- dependent kinase A activation. Am J Physiol Gastrointest Liver Physiol. 2007, 293:G673-81.
25. Gill C, Boyd A, McDermott E. Potential anti-cancer effects of virgin olive oil phenols on colorectal carcinogenesis models in vitro. Int J Cancer. 2005, 117:1-7.
26. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990, 186:407-21.
27. Yokomizo A, Moriwaki M. Effects of uptake of flavonoids on oxidative stress induced by hydrogen peroxide in human intestinal Caco-2 cells. Biosci Biotechnol Biochem. 2006, 70:1317-24.
28. Commane DM, Shortt CT, Silvi S. Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Nutr Cancer. 2005, 51:102-9.
29. Lipkin M. Proliferation and differentiation of normal and diseased gastrointestinal cells. Physiology of the gastrointestinal tract 1987, 255-84. Johnson LR. editor, New York, Raven, pp
30. Martinez-Palamo A. Ultrastructural modifications of intercellular junctions between tumor cells. In Vitro. 1970, 6:15-20.
31. Dhawan P, Singh AB, Deane NG. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest. 2005, 115:1765-76.
32. Viswanathan VK, Koutsouris A, Lukic S. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function. Infect. Immun. 2004, 72:3218-27.
33. Morita H, Katsuno T, Hoshimoto A. Connexin 26-mediated gap junctional intercellular communication suppresses paracellular permeability of human intetsinal epithelial cell monolayers. Exp Cell Res. 2004, 1:1-8.
34. Fässler C, Gill CI, Arrigoni E. Fermentation of resistant starches: influence of in vitro models on colon carcinogenesis. Nutr Cancer. 2007, 58:85-92.
35. Bellion P, Hofmann T, Pool-Zobel BL. Antioxidant effectiveness of phenolic apple juice extracts and their gut fermentation products in the human colon carcinoma cell line caco-2. J Agric Food Chem. 2008, 56:6310-7.
36. Renis M, Calandra L, Scifo C. Response of cell cycle/stress-related protein expression and DNA damage upon treatment of CaCo2 cells with anthocyanins. Br J Nutr. 2008, 100:27-35.
37. Steer HW, Colin-Jones DG. Melanosis coli: studies of the toxic effects of irritant purgatives. J Pathol. 1975, 115:199-205.
38. Yagi T, Miyawaki Y, Yamauchi K. Involvement of prostaglandin E-like material in the propulsive action oh rhein anthrone, the intraluminal active metabolite of Sennosides A and B in mice. J Pharm Pharmacol. 1988, 40:27-30.
39. Laitinen L, Takala E, Vuorela H. Anthranoid laxatives influence the absorption of poorly permeable drugs in human intestinal cell culture model (Caco-2). Eur J Pharm Biopharm. 2007, 66:135-45.
40. Schörkhuber M, Richter M, Dutter A. Effect of anthraquinone-laxatives on the proliferation and urokinase secretion of normal, premalignant and malignant colonic epithelial cells. Eur J Cancer. 1998, 34:1091-8.
41. Geboes K, Nijs G, Mengs U. Effects of 'contact laxatives' on intestinal and colonic epithelial cell proliferation. Pharmacology. 1993, 47:187-95.
42. Geboes K. Laxatives and intestinal epithelial cells: a morphological study of epithelial cell damage and proliferation. Verh K Acad Geneeskd Belg. 1995, 57:51-74.
43. Cichewicz RH, Seeram NP, Zhang Y. Anti-tumor effects of novel anthraquinones from daylilies against human cancer cell lines. Life Sci. 2004, 74:1791-9.
44. Mascolo N, Mereto E, Borrelli F. Does senna extract promote growth of aberrant crypt foci and malignant tumors in rat colon. Dig Dis Sci. 1999, 44:2226-30.
45. Borrelli F, Capasso R, Aviello G. Senna and the formation of aberrant crypt foci and tumors in rats treated with azoxymethane. Phytomed. 2005, 12:501-5.
46. Pearson G, Robinson F, Beers Gibson T. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001, 22:153-83.
47. Junttila MR, Li SP, Westermarck J. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J. 2008, 22:954-65.
48. Chambard JC, Lefloch R, Pouysségur J. ERK implication in cell cycle regulation. Biochim Biophys Acta. 2007, 1773:1299-310.
49. Meloche S, Pouysségur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene. 2007, 26:3227-39.
50. Legendre F, Bogdanowicz P, Martin G. Rhein, a diacerhein-derived metabolite, modulates the expression of matrix degrading enzymes and the cell proliferation of articular chondrocytes by inhibiting ERK and JNK-AP-1 dependent pathways. Clin Exp Rheumatol. 2007, 25:546-55.
51. Chen Z, Liu YM, Yang S. Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb. Bioorg Med Chem. 2008, 16:1337-44.
52. Zhou X, Song B, Jin L, Hu D, Diao C, Xu G, Zou Z, Yang S. Isolation and inhibitory activity against ERK phosphorylation of hydroxyanthraquinones from rhubarb. Bioorg Med Chem Lett. 2006, 16:563-8.
53. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med. 1996, 74:297-312.
54. Wargovich MJ, Goldberg MT, Newmarck HL. Nuclear aberrations as a short-term test for genotoxicity to the colon: evaluation of nineteen agents in mice. J Natl Cancer Inst. 1983, 71:133-7.
55. Ronen A, Heddle JA. Site-specific induction of nuclear anomalies (apoptotic bodies and micronuclei) by carcinogens in mice. Cancer Res. 1984, 44:1536-40.
56. Wu CH, Yen GC. Antigenotoxic properties of Cassia tea (Cassia tora L.): mechanism of action and the influence of roasting process. Life Sci. 2004, 76:85-101.
57. Nakabeppu Y, Sakumi K, Sakamoto K. Mutagenesis and carcinogenesis caused by the oxidation of nucleic acids. Biol Chem. 2006, 387:373-9.
58. Karihtala P, Soini Y. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS. 2007, 115:81-103.